Home

ERROL B DESOUZA

CIK 1213895 · CEO · last filed 2026-06-17

ERROL B DESOUZA is a CEO who has filed 82 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for RPRX, was dated Aug 12, 2026. Across all open-market trades the lifetime net is +$33.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $12.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.53M

Companies

7

Total Filings

82

Lifetime Open-Market Net

$33.4K

Filer Profile

Reported Address
215 COLLEGE ROAD
PARAMUS, NJ 07652
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALEC Director 98,650 $2.14 $211.1K $0 3 2026-06-17
RPRX Director 81,352 $58.61 $4.77M $0 7 2025-05-14
CYCN Director 7,143 $23.52 $168.0K $0 3 2023-12-04
CBIO Director 1,987 $19.41 $38.6K $0 20 2021-10-05
ALBIREO PHARMA, INC. (BIOD) Delisted CEO 5,314 — — $33.4K 18 2015-10-02
PTN Director — $11.80 — $0 4 2010-07-23
IDXX Director 14,552 $504.70 $7.34M $0 13 2009-05-01

Recent Filings

82 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-12 RPRX Notice (144) −206,352 -$11.93M EDGAR
2026-08-12 RPRX Notice (144) −125,000 -$7.22M EDGAR
2026-06-17 ALEC Grant (A) +28,700 $0 EDGAR
2025-06-12 ALEC Grant (A) +28,700 $0 EDGAR
2025-05-14 RPRX Grant (A) +7,614 $0 EDGAR
2024-06-10 RPRX Grant (A) +9,293 $0 EDGAR
2024-03-21 ALEC Grant (A) +41,250 $0 EDGAR
2023-12-04 CYCN Grant (A) +50,000 $0 EDGAR
2023-06-26 RPRX Grant (A) +7,747 $0 EDGAR
2022-06-24 RPRX Grant (A) +6,328 $0 EDGAR
Showing 1–10 of 82
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.